0 XP   0   0   0

Coloplast A/S










Financial Health of Coloplast




Comparing to competitors in the Medical Instruments & Supplies industry




  Industry Rankings  


Coloplast A/S
Buy, Hold or Sell?

Should you buy, hold or sell Coloplast?

I guess you are interested in Coloplast A/S. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Coloplast

Let's start. I'm going to help you getting a better view of Coloplast A/S. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Coloplast A/S even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Coloplast A/S is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Coloplast A/S. The closing price on 2022-12-02 was kr871.60 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Coloplast A/S Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

1.1. Profitability of Coloplast A/S.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Coloplast earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 20.3% means that kr0.20 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Coloplast A/S:

  • The MRQ is 20.3%. The company is making a huge profit. +2
  • The TTM is 20.9%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ20.3%TTM20.9%-0.6%
TTM20.9%YOY24.8%-3.9%
TTM20.9%5Y22.7%-1.8%
5Y22.7%10Y20.9%+1.8%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ20.3%7.5%+12.8%
TTM20.9%7.3%+13.6%
YOY24.8%8.7%+16.1%
5Y22.7%6.8%+15.9%
10Y20.9%7.0%+13.9%
1.1.2. Return on Assets

Shows how efficient Coloplast is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • 3.5% Return on Assets means that Coloplast generated kr0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Coloplast A/S:

  • The MRQ is 3.5%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.5%TTM4.4%-0.8%
TTM4.4%YOY7.8%-3.5%
TTM4.4%5Y7.1%-2.8%
5Y7.1%10Y6.7%+0.5%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5%1.5%+2.0%
TTM4.4%1.4%+3.0%
YOY7.8%1.5%+6.3%
5Y7.1%1.2%+5.9%
10Y6.7%1.3%+5.4%
1.1.3. Return on Equity

Shows how efficient Coloplast is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • 14.8% Return on Equity means Coloplast generated kr0.15 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Coloplast A/S:

  • The MRQ is 14.8%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 16.2%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ14.8%TTM16.2%-1.4%
TTM16.2%YOY17.5%-1.3%
TTM16.2%5Y16.9%-0.7%
5Y16.9%10Y14.4%+2.5%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ14.8%2.4%+12.4%
TTM16.2%2.6%+13.6%
YOY17.5%2.9%+14.6%
5Y16.9%2.3%+14.6%
10Y14.4%2.4%+12.0%

1.2. Operating Efficiency of Coloplast A/S.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Coloplast is operating .

  • Measures how much profit Coloplast makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 30.3% means the company generated kr0.30  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Coloplast A/S:

  • The MRQ is 30.3%. The company is operating very efficient. +2
  • The TTM is 28.8%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ30.3%TTM28.8%+1.5%
TTM28.8%YOY32.2%-3.4%
TTM28.8%5Y30.3%-1.5%
5Y30.3%10Y28.1%+2.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ30.3%10.1%+20.2%
TTM28.8%9.8%+19.0%
YOY32.2%10.8%+21.4%
5Y30.3%7.9%+22.4%
10Y28.1%7.2%+20.9%
1.2.2. Operating Ratio

Measures how efficient Coloplast is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 1.01 means that the operating costs are kr1.01 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Coloplast A/S:

  • The MRQ is 1.012. The company is inefficient in keeping operating costs low. -1
  • The TTM is 0.848. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ1.012TTM0.848+0.164
TTM0.848YOY0.673+0.176
TTM0.8485Y0.717+0.131
5Y0.71710Y0.696+0.022
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0121.172-0.160
TTM0.8481.094-0.246
YOY0.6730.990-0.317
5Y0.7171.046-0.329
10Y0.6961.006-0.310

1.3. Liquidity of Coloplast A/S.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Coloplast is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 1.20 means the company has kr1.20 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Coloplast A/S:

  • The MRQ is 1.196. The company is just able to pay all its short-term debts.
  • The TTM is 0.848. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ1.196TTM0.848+0.348
TTM0.848YOY0.976-0.128
TTM0.8485Y1.014-0.166
5Y1.01410Y1.261-0.247
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1962.529-1.333
TTM0.8482.586-1.738
YOY0.9762.402-1.426
5Y1.0142.490-1.476
10Y1.2612.359-1.098
1.3.2. Quick Ratio

Measures if Coloplast is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.66 means the company can pay off kr0.66 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Coloplast A/S:

  • The MRQ is 0.665. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.502. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.665TTM0.502+0.163
TTM0.502YOY0.651-0.149
TTM0.5025Y0.673-0.171
5Y0.67310Y0.599+0.074
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6651.102-0.437
TTM0.5021.064-0.562
YOY0.6511.119-0.468
5Y0.6731.094-0.421
10Y0.5991.026-0.427

1.4. Solvency of Coloplast A/S.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Coloplast assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Coloplast to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.76 means that Coloplast assets are financed with 76.3% credit (debt) and the remaining percentage (100% - 76.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Coloplast A/S:

  • The MRQ is 0.763. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.738. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.763TTM0.738+0.025
TTM0.738YOY0.549+0.189
TTM0.7385Y0.576+0.163
5Y0.57610Y0.519+0.056
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7630.347+0.416
TTM0.7380.341+0.397
YOY0.5490.368+0.181
5Y0.5760.376+0.200
10Y0.5190.372+0.147
1.4.2. Debt to Equity Ratio

Measures if Coloplast is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 321.6% means that company has kr3.22 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Coloplast A/S:

  • The MRQ is 3.216. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.102. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.216TTM3.102+0.113
TTM3.102YOY1.239+1.863
TTM3.1025Y1.563+1.539
5Y1.56310Y1.264+0.299
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2160.517+2.699
TTM3.1020.520+2.582
YOY1.2390.591+0.648
5Y1.5630.628+0.935
10Y1.2640.632+0.632

2. Market Valuation of Coloplast A/S

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Coloplast generates.

  • Above 15 is considered overpriced but always compare Coloplast to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 131.90 means the investor is paying kr131.90 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Coloplast A/S:

  • The EOD is 148.191. Seems overpriced? -1
  • The MRQ is 131.903. Seems overpriced? -1
  • The TTM is 172.175. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD148.191MRQ131.903+16.288
MRQ131.903TTM172.175-40.273
TTM172.175YOY173.307-1.132
TTM172.1755Y166.175+6.000
5Y166.17510Y15.647+150.528
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD148.19159.546+88.645
MRQ131.90361.746+70.157
TTM172.17585.285+86.890
YOY173.30798.197+75.110
5Y166.17557.263+108.912
10Y15.64753.213-37.566
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Coloplast.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Coloplast A/S:

  • The MRQ is -2,749.838. Very Bad. -2
  • The TTM is -1,425.903. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-2,749.838TTM-1,425.903-1,323.935
TTM-1,425.903YOY-10,020.132+8,594.229
TTM-1,425.9035Y-2,348.745+922.842
5Y-2,348.74510Y-1,424.945-923.800
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,749.838-0.016-2,749.822
TTM-1,425.903-0.191-1,425.712
YOY-10,020.1320.014-10,020.146
5Y-2,348.7450.044-2,348.789
10Y-1,424.9450.101-1,425.046

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Coloplast is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 19.57 means the investor is paying kr19.57 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Coloplast A/S:

  • The EOD is 21.982. Seems overpriced? -1
  • The MRQ is 19.566. Seems overpriced? -1
  • The TTM is 27.743. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD21.982MRQ19.566+2.416
MRQ19.566TTM27.743-8.177
TTM27.743YOY30.379-2.636
TTM27.7435Y27.610+0.133
5Y27.61010Y22.946+4.664
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD21.9822.751+19.231
MRQ19.5662.850+16.716
TTM27.7433.702+24.041
YOY30.3794.453+25.926
5Y27.6103.597+24.013
10Y22.9463.186+19.760
2. Total Gains per Share

2.4. Latest News of Coloplast A/S

Does Coloplast A/S still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Coloplast A/S to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-12-01
17:33
Coloplast A/S - Announcement no. 14/2022 - Articles of AssociationRead
2022-12-01
17:29
Coloplast A/S - Announcement no. 13/2022 - Decisions at the Annual General Meeting 2022Read
2022-11-18
16:00
Coloplast Launches New Catheter in the U.S.Read
2022-11-15
16:00
Coloplast appoints new President of its global Interventional Urology businessRead
2022-11-10
10:00
Coloplast enters into Power Purchase Agreement with Better EnergyRead
2022-11-08
13:59
 Coloplast A/S - Announcement no. 12/2022 - Notice of Annual General MeetingRead
2022-11-07
18:19
Coloplast A/S - Announcement no. 11/2022 - Sustainability Report 2021/22Read
2022-11-07
18:09
Coloplast A/S - Announcement no. 10/2022 - Annual Report 2021/22 & Remuneration Report 2021/22Read
2022-11-07
18:09
Coloplast A/S - Announcement no. 10/2022 - Annual Report 2021/22 & Remuneration Report 2021/22Read
2022-11-07
13:05
Coloplast A/S Announcement no. 9/2022 - Full-Year Financial Results 2021/22Read

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Coloplast A/S compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--4.8630.321+1414%0.887+449%0.581+737%0.272+1688%
Book Value Growth--0.8760.857+2%0.859+2%0.859+2%0.858+2%
Book Value Per Share--39.65134.685+14%32.628+22%30.318+31%28.067+41%
Book Value Per Share Growth--0.123-0.004+103%0.008+1380%0.003+3670%-0.004+103%
Current Ratio--1.1960.848+41%0.976+23%1.014+18%1.261-5%
Debt To Asset Ratio--0.7630.738+3%0.549+39%0.576+33%0.519+47%
Debt To Equity Ratio--3.2163.102+4%1.239+160%1.563+106%1.264+154%
Dividend Per Share---6.016-100%9.241-100%7.471-100%5.498-100%
Eps--5.8825.579+5%5.662+4%5.048+17%4.042+46%
Eps Growth---0.048-0.027-44%0.054-189%0.001-3446%-0.986+1956%
Gross Profit Margin--1.0000.278+260%-0.138+114%-0.144+114%1.042-4%
Net Profit Margin--0.2030.209-3%0.248-18%0.227-10%0.209-3%
Operating Margin--0.3030.288+5%0.322-6%0.303+0%0.281+8%
Operating Ratio--1.0120.848+19%0.673+50%0.717+41%0.696+45%
Pb Ratio21.982+11%19.56627.743-29%30.379-36%27.610-29%22.946-15%
Pe Ratio148.191+11%131.903172.175-23%173.307-24%166.175-21%15.647+743%
Peg Ratio---2749.838-1425.903-48%-10020.132+264%-2348.745-15%-1424.945-48%
Price Per Share871.600+11%775.800939.925-17%979.725-21%836.190-7%645.745+20%
Price To Total Gains Ratio179.228+11%159.528153.387+4%132.488+20%135.140+18%113.446+41%
Profit Growth--85.14085.3910%86.587-2%85.832-1%62.988+35%
Quick Ratio--0.6650.502+33%0.651+2%0.673-1%0.599+11%
Return On Assets--0.0350.044-19%0.078-55%0.071-51%0.067-47%
Return On Equity--0.1480.162-8%0.175-15%0.169-12%0.144+3%
Revenue Growth--0.8630.8640%0.862+0%0.861+0%0.861+0%
Total Gains Per Share--4.8636.337-23%10.128-52%8.051-40%5.770-16%
Total Gains Per Share Growth---0.178-0.704+296%-0.587+230%-0.554+212%-0.443+149%
Usd Book Value--1175805600.0001037231550.000+13%985545450.000+19%913114010.000+29%846184410.000+39%
Usd Book Value Change Per Share--0.6900.046+1414%0.126+449%0.082+737%0.039+1688%
Usd Book Value Per Share--5.6224.918+14%4.627+22%4.299+31%3.980+41%
Usd Dividend Per Share---0.853-100%1.310-100%1.059-100%0.780-100%
Usd Eps--0.8340.791+5%0.803+4%0.716+17%0.573+46%
Usd Price Per Share123.593+11%110.008133.281-17%138.925-21%118.572-7%91.567+20%
Usd Profit--174414000.000166827700.000+5%171046250.000+2%152052140.000+15%121898370.000+43%
Usd Revenue--859166200.000800425550.000+7%688651700.000+25%673103330.000+28%578253310.000+49%
Usd Total Gains Per Share--0.6900.899-23%1.436-52%1.142-40%0.818-16%
 EOD+2 -3MRQTTM+21 -14YOY+20 -155Y+21 -1410Y+22 -13

3.2. Fundamental Score

Let's check the fundamental score of Coloplast A/S based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15148.191
Price to Book Ratio (EOD)Between0-121.982
Net Profit Margin (MRQ)Greater than00.203
Operating Margin (MRQ)Greater than00.303
Quick Ratio (MRQ)Greater than10.665
Current Ratio (MRQ)Greater than11.196
Debt to Asset Ratio (MRQ)Less than10.763
Debt to Equity Ratio (MRQ)Less than13.216
Return on Equity (MRQ)Greater than0.150.148
Return on Assets (MRQ)Greater than0.050.035
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Coloplast A/S based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.471
Ma 20Greater thanMa 50868.730
Ma 50Greater thanMa 100824.740
Ma 100Greater thanMa 200838.406
OpenGreater thanClose847.600
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in DKK. All numbers in thousands.

Summary
Total Assets34,956,000
Total Liabilities26,664,000
Total Stockholder Equity8,292,000
 As reported
Total Liabilities 26,664,000
Total Stockholder Equity+ 8,292,000
Total Assets = 34,956,000

Assets

Total Assets34,956,000
Total Current Assets8,772,000
Long-term Assets8,772,000
Total Current Assets
Cash And Cash Equivalents 414,000
Short-term Investments 219,000
Net Receivables 4,659,000
Inventory 3,187,000
Total Current Assets  (as reported)8,772,000
Total Current Assets  (calculated)8,479,000
+/- 293,000
Long-term Assets
Property Plant Equipment 4,133,000
Goodwill 11,808,000
Intangible Assets 8,469,000
Other Assets 1,891,000
Long-term Assets  (as reported)26,184,000
Long-term Assets  (calculated)26,301,000
+/- 117,000

Liabilities & Shareholders' Equity

Total Current Liabilities7,336,000
Long-term Liabilities19,328,000
Total Stockholder Equity8,292,000
Total Current Liabilities
Short Long Term Debt 1,644,000
Accounts payable 1,242,000
Other Current Liabilities 4,235,000
Total Current Liabilities  (as reported)7,336,000
Total Current Liabilities  (calculated)7,121,000
+/- 215,000
Long-term Liabilities
Long term Debt 16,359,000
Capital Lease Obligations Min Short Term Debt705,000
Other Liabilities 2,473,000
Long-term Liabilities Other 7,000
Long-term Liabilities  (as reported)19,328,000
Long-term Liabilities  (calculated)19,544,000
+/- 216,000
Total Stockholder Equity
Common Stock216,000
Retained Earnings 8,571,000
Other Stockholders Equity -495,000
Total Stockholder Equity (as reported)8,292,000
Total Stockholder Equity (calculated)8,292,000
+/-0
Other
Capital Stock216,000
Common Stock Shares Outstanding 209,127
Net Debt 17,589,000
Net Invested Capital 26,295,000
Net Tangible Assets -11,817,000
Net Working Capital 1,436,000



Balance Sheet

Currency in DKK. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-31
> Total Assets 
0
0
0
7,963,000
7,545,000
7,620,000
7,912,000
7,771,000
8,116,000
8,228,000
8,493,000
9,218,000
8,916,000
9,300,000
9,980,000
10,176,000
9,773,000
10,066,000
8,637,000
9,364,000
8,403,000
9,278,000
9,121,000
10,379,000
9,663,000
10,620,000
9,945,000
10,817,000
10,810,000
10,602,000
11,280,000
11,007,000
12,883,000
12,511,000
12,247,000
12,050,000
12,193,000
12,751,000
12,667,000
11,769,000
12,113,000
12,292,000
12,551,000
12,732,000
13,223,000
13,528,000
13,315,000
13,499,000
14,926,000
15,249,000
15,458,000
15,841,000
16,188,000
35,170,000
35,185,000
34,956,000
34,956,00035,185,00035,170,00016,188,00015,841,00015,458,00015,249,00014,926,00013,499,00013,315,00013,528,00013,223,00012,732,00012,551,00012,292,00012,113,00011,769,00012,667,00012,751,00012,193,00012,050,00012,247,00012,511,00012,883,00011,007,00011,280,00010,602,00010,810,00010,817,0009,945,00010,620,0009,663,00010,379,0009,121,0009,278,0008,403,0009,364,0008,637,00010,066,0009,773,00010,176,0009,980,0009,300,0008,916,0009,218,0008,493,0008,228,0008,116,0007,771,0007,912,0007,620,0007,545,0007,963,000000
   > Total Current Assets 
0
0
0
3,369,000
2,997,000
3,007,000
3,188,000
3,353,000
3,491,000
3,775,000
4,145,000
4,965,000
4,664,000
5,128,000
5,720,000
5,969,000
5,654,000
5,975,000
4,551,000
5,366,000
4,426,000
5,095,000
4,972,000
6,047,000
5,251,000
5,884,000
5,338,000
5,765,000
5,733,000
6,009,000
6,646,000
6,164,000
6,915,000
6,608,000
6,518,000
6,194,000
6,322,000
6,641,000
6,494,000
5,590,000
5,929,000
6,097,000
6,415,000
6,359,000
6,361,000
6,709,000
6,490,000
6,489,000
6,640,000
6,707,000
6,827,000
6,994,000
7,284,000
8,169,000
8,703,000
8,772,000
8,772,0008,703,0008,169,0007,284,0006,994,0006,827,0006,707,0006,640,0006,489,0006,490,0006,709,0006,361,0006,359,0006,415,0006,097,0005,929,0005,590,0006,494,0006,641,0006,322,0006,194,0006,518,0006,608,0006,915,0006,164,0006,646,0006,009,0005,733,0005,765,0005,338,0005,884,0005,251,0006,047,0004,972,0005,095,0004,426,0005,366,0004,551,0005,975,0005,654,0005,969,0005,720,0005,128,0004,664,0004,965,0004,145,0003,775,0003,491,0003,353,0003,188,0003,007,0002,997,0003,369,000000
       Cash And Cash Equivalents 
0
0
0
629,000
278,000
237,000
335,000
475,000
350,000
381,000
454,000
1,318,000
848,000
1,496,000
1,914,000
1,973,000
988,000
1,417,000
617,000
1,504,000
462,000
454,000
404,000
971,000
428,000
656,000
644,000
881,000
412,000
402,000
424,000
546,000
545,000
442,000
314,000
314,000
505,000
608,000
450,000
297,000
432,000
312,000
444,000
356,000
516,000
498,000
411,000
323,000
435,000
418,000
447,000
448,000
642,000
517,000
634,000
414,000
414,000634,000517,000642,000448,000447,000418,000435,000323,000411,000498,000516,000356,000444,000312,000432,000297,000450,000608,000505,000314,000314,000442,000545,000546,000424,000402,000412,000881,000644,000656,000428,000971,000404,000454,000462,0001,504,000617,0001,417,000988,0001,973,0001,914,0001,496,000848,0001,318,000454,000381,000350,000475,000335,000237,000278,000629,000000
       Short-term Investments 
0
0
0
1,000
1,000
1,000
1,000
1,000
1,000
180,000
471,000
568,000
659,000
456,000
608,000
645,000
1,337,000
1,149,000
335,000
367,000
475,000
632,000
401,000
619,000
200,000
216,000
210,000
519,000
201,000
200,000
200,000
489,000
379,000
334,000
313,000
315,000
316,000
311,000
311,000
310,000
305,000
308,000
311,000
313,000
304,000
302,000
262,000
262,000
257,000
257,000
228,000
226,000
222,000
220,000
220,000
219,000
219,000220,000220,000222,000226,000228,000257,000257,000262,000262,000302,000304,000313,000311,000308,000305,000310,000311,000311,000316,000315,000313,000334,000379,000489,000200,000200,000201,000519,000210,000216,000200,000619,000401,000632,000475,000367,000335,0001,149,0001,337,000645,000608,000456,000659,000568,000471,000180,0001,0001,0001,0001,0001,0001,000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,124,000
3,222,000
3,190,000
3,071,000
3,174,000
3,201,000
3,085,000
3,120,000
3,113,000
3,227,000
3,153,000
3,399,000
3,794,000
3,526,000
3,514,000
3,545,000
3,563,000
3,609,000
3,720,000
3,742,000
4,321,000
4,613,000
4,659,000
4,659,0004,613,0004,321,0003,742,0003,720,0003,609,0003,563,0003,545,0003,514,0003,526,0003,794,0003,399,0003,153,0003,227,0003,113,0003,120,0003,085,0003,201,0003,174,0003,071,0003,190,0003,222,0003,124,000000000000000000000000000000000000
       Other Current Assets 
0
0
0
1,753,000
1,803,000
1,788,000
1,890,000
1,918,000
2,156,000
2,182,000
2,220,000
2,133,000
2,200,000
2,231,000
2,236,000
2,343,000
2,305,000
2,349,000
2,512,000
2,426,000
2,407,000
2,846,000
2,949,000
3,135,000
3,239,000
3,545,000
3,000,000
2,892,000
3,615,000
3,952,000
4,520,000
3,611,000
4,365,000
4,090,000
4,149,000
3,873,000
3,815,000
4,043,000
4,054,000
3,258,000
3,374,000
3,608,000
3,746,000
3,757,000
3,624,000
3,994,000
3,701,000
3,677,000
3,717,000
3,743,000
3,774,000
3,892,000
3,923,000
4,562,000
0
0
004,562,0003,923,0003,892,0003,774,0003,743,0003,717,0003,677,0003,701,0003,994,0003,624,0003,757,0003,746,0003,608,0003,374,0003,258,0004,054,0004,043,0003,815,0003,873,0004,149,0004,090,0004,365,0003,611,0004,520,0003,952,0003,615,0002,892,0003,000,0003,545,0003,239,0003,135,0002,949,0002,846,0002,407,0002,426,0002,512,0002,349,0002,305,0002,343,0002,236,0002,231,0002,200,0002,133,0002,220,0002,182,0002,156,0001,918,0001,890,0001,788,0001,803,0001,753,000000
   > Long-term Assets 
0
0
0
4,594,000
4,548,000
4,613,000
4,724,000
4,418,000
4,625,000
4,453,000
4,348,000
4,253,000
4,252,000
4,172,000
4,260,000
4,207,000
4,119,000
4,091,000
4,086,000
3,998,000
3,977,000
4,183,000
4,149,000
4,332,000
4,412,000
4,736,000
4,607,000
5,052,000
5,077,000
4,593,000
4,634,000
4,843,000
5,968,000
5,903,000
5,729,000
5,856,000
5,871,000
6,110,000
6,173,000
6,179,000
6,184,000
6,195,000
6,136,000
6,373,000
6,862,000
6,819,000
6,825,000
7,010,000
8,286,000
8,542,000
8,631,000
8,847,000
8,904,000
27,001,000
26,482,000
26,184,000
26,184,00026,482,00027,001,0008,904,0008,847,0008,631,0008,542,0008,286,0007,010,0006,825,0006,819,0006,862,0006,373,0006,136,0006,195,0006,184,0006,179,0006,173,0006,110,0005,871,0005,856,0005,729,0005,903,0005,968,0004,843,0004,634,0004,593,0005,077,0005,052,0004,607,0004,736,0004,412,0004,332,0004,149,0004,183,0003,977,0003,998,0004,086,0004,091,0004,119,0004,207,0004,260,0004,172,0004,252,0004,253,0004,348,0004,453,0004,625,0004,418,0004,724,0004,613,0004,548,0004,594,000000
       Property Plant Equipment 
0
0
0
2,635,000
2,596,000
2,601,000
2,596,000
5,827,000
2,435,000
2,392,000
2,349,000
2,266,000
2,094,000
2,240,000
2,092,000
2,286,000
2,257,000
2,218,000
2,267,000
2,286,000
2,317,000
2,309,000
2,368,000
2,462,000
2,516,000
2,712,000
2,669,000
2,705,000
2,727,000
2,717,000
2,762,000
2,925,000
2,919,000
2,928,000
2,937,000
3,072,000
3,134,000
3,125,000
3,151,000
3,169,000
3,175,000
3,179,000
3,146,000
3,249,000
3,786,000
3,760,000
3,798,000
3,926,000
4,045,000
4,168,000
4,232,000
4,386,000
4,421,000
4,884,000
4,920,000
4,133,000
4,133,0004,920,0004,884,0004,421,0004,386,0004,232,0004,168,0004,045,0003,926,0003,798,0003,760,0003,786,0003,249,0003,146,0003,179,0003,175,0003,169,0003,151,0003,125,0003,134,0003,072,0002,937,0002,928,0002,919,0002,925,0002,762,0002,717,0002,727,0002,705,0002,669,0002,712,0002,516,0002,462,0002,368,0002,309,0002,317,0002,286,0002,267,0002,218,0002,257,0002,286,0002,092,0002,240,0002,094,0002,266,0002,349,0002,392,0002,435,0005,827,0002,596,0002,601,0002,596,0002,635,000000
       Goodwill 
0
0
0
629,000
639,000
674,000
732,000
670,000
785,000
746,000
736,000
737,000
764,000
743,000
783,000
0
750,000
768,000
757,000
735,000
723,000
726,000
730,000
772,000
799,000
877,000
847,000
842,000
862,000
834,000
847,000
844,000
1,800,000
1,772,000
1,665,000
1,724,000
0
0
0
1,984,000
0
0
0
2,030,000
0
0
0
1,976,000
0
0
0
2,028,000
0
10,130,000
0
11,808,000
11,808,000010,130,00002,028,0000001,976,0000002,030,0000001,984,0000001,724,0001,665,0001,772,0001,800,000844,000847,000834,000862,000842,000847,000877,000799,000772,000730,000726,000723,000735,000757,000768,000750,0000783,000743,000764,000737,000736,000746,000785,000670,000732,000674,000639,000629,000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,000
12,000
10,000
10,000
10,000
10,000
10,000
10,000
10,000
10,000
5,000
5,000
0
0
0
0
0
0
0
0
0
0
0
000000000005,0005,00010,00010,00010,00010,00010,00010,00010,00010,00012,00012,000000000000000000000000000000000000
       Intangible Assets 
0
0
0
1,179,000
1,162,000
1,184,000
1,220,000
123,000
1,201,000
1,114,000
1,064,000
1,065,000
1,193,000
989,000
1,179,000
0
883,000
867,000
827,000
781,000
742,000
713,000
690,000
709,000
705,000
740,000
697,000
669,000
652,000
604,000
583,000
553,000
732,000
686,000
619,000
571,000
2,248,000
2,495,000
2,533,000
534,000
2,516,000
2,517,000
2,486,000
472,000
2,459,000
0
0
388,000
0
0
0
1,623,000
0
11,069,000
0
8,469,000
8,469,000011,069,00001,623,000000388,000002,459,000472,0002,486,0002,517,0002,516,000534,0002,533,0002,495,0002,248,000571,000619,000686,000732,000553,000583,000604,000652,000669,000697,000740,000705,000709,000690,000713,000742,000781,000827,000867,000883,00001,179,000989,0001,193,0001,065,0001,064,0001,114,0001,201,000123,0001,220,0001,184,0001,162,0001,179,000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
900,000
893,000
884,000
479,000
480,000
479,000
800,000
483,000
489,000
494,000
1,078,000
612,000
599,000
604,000
1,533,000
692,000
735,000
740,000
1,655,000
765,000
877,000
876,000
1,891,000
1,891,000876,000877,000765,0001,655,000740,000735,000692,0001,533,000604,000599,000612,0001,078,000494,000489,000483,000800,000479,000480,000479,000884,000893,000900,000000000000000000000000000000000000
> Total Liabilities 
0
0
0
5,113,000
4,666,000
4,540,000
4,790,000
4,319,000
4,594,000
4,454,000
4,506,000
4,740,000
4,476,000
4,332,000
4,582,000
4,134,000
3,852,000
3,716,000
2,482,000
2,595,000
2,313,000
3,431,000
3,698,000
4,096,000
4,268,000
4,147,000
4,152,000
6,111,000
6,784,000
5,679,000
6,781,000
5,939,000
8,669,000
7,447,000
7,289,000
6,098,000
7,482,000
7,375,000
7,465,000
5,351,000
6,921,000
6,119,000
6,612,000
5,819,000
7,772,000
6,942,000
6,953,000
6,093,000
9,156,000
8,313,000
8,531,000
7,673,000
9,769,000
27,897,000
27,910,000
26,664,000
26,664,00027,910,00027,897,0009,769,0007,673,0008,531,0008,313,0009,156,0006,093,0006,953,0006,942,0007,772,0005,819,0006,612,0006,119,0006,921,0005,351,0007,465,0007,375,0007,482,0006,098,0007,289,0007,447,0008,669,0005,939,0006,781,0005,679,0006,784,0006,111,0004,152,0004,147,0004,268,0004,096,0003,698,0003,431,0002,313,0002,595,0002,482,0003,716,0003,852,0004,134,0004,582,0004,332,0004,476,0004,740,0004,506,0004,454,0004,594,0004,319,0004,790,0004,540,0004,666,0005,113,000000
   > Total Current Liabilities 
0
0
0
1,987,000
1,804,000
1,898,000
2,239,000
2,058,000
1,801,000
1,670,000
1,714,000
2,087,000
1,904,000
1,751,000
3,415,000
3,708,000
3,406,000
3,263,000
2,061,000
2,266,000
1,980,000
2,041,000
2,935,000
3,529,000
3,815,000
3,814,000
3,845,000
4,578,000
5,546,000
4,781,000
6,317,000
5,309,000
8,220,000
6,982,000
6,836,000
5,425,000
6,826,000
6,701,000
6,800,000
4,708,000
6,281,000
5,453,000
5,955,000
4,942,000
6,648,000
5,894,000
5,923,000
4,979,000
7,782,000
6,822,000
7,116,000
6,314,000
8,477,000
24,811,000
8,635,000
7,336,000
7,336,0008,635,00024,811,0008,477,0006,314,0007,116,0006,822,0007,782,0004,979,0005,923,0005,894,0006,648,0004,942,0005,955,0005,453,0006,281,0004,708,0006,800,0006,701,0006,826,0005,425,0006,836,0006,982,0008,220,0005,309,0006,317,0004,781,0005,546,0004,578,0003,845,0003,814,0003,815,0003,529,0002,935,0002,041,0001,980,0002,266,0002,061,0003,263,0003,406,0003,708,0003,415,0001,751,0001,904,0002,087,0001,714,0001,670,0001,801,0002,058,0002,239,0001,898,0001,804,0001,987,000000
       Short-term Debt 
0
0
0
233,000
264,000
335,000
345,000
172,000
207,000
174,000
113,000
98,000
156,000
0
1,343,000
1,296,000
1,335,000
1,311,000
146,000
111,000
129,000
130,000
154,000
92,000
367,000
467,000
779,000
100,000
391,000
25,000
923,000
222,000
2,880,000
2,662,000
2,547,000
1,358,000
2,895,000
3,183,000
2,975,000
1,270,000
3,045,000
2,592,000
2,848,000
1,074,000
3,156,000
2,767,000
2,671,000
1,317,000
4,194,000
3,670,000
3,848,000
2,337,000
4,606,000
20,601,000
0
0
0020,601,0004,606,0002,337,0003,848,0003,670,0004,194,0001,317,0002,671,0002,767,0003,156,0001,074,0002,848,0002,592,0003,045,0001,270,0002,975,0003,183,0002,895,0001,358,0002,547,0002,662,0002,880,000222,000923,00025,000391,000100,000779,000467,000367,00092,000154,000130,000129,000111,000146,0001,311,0001,335,0001,296,0001,343,0000156,00098,000113,000174,000207,000172,000345,000335,000264,000233,000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,662,000
2,547,000
1,358,000
2,895,000
3,183,000
2,975,000
1,262,000
3,039,000
2,584,000
2,840,000
1,066,000
2,989,000
2,616,000
2,515,000
1,111,000
4,021,000
3,501,000
3,683,000
2,160,000
4,435,000
20,392,000
3,514,000
1,644,000
1,644,0003,514,00020,392,0004,435,0002,160,0003,683,0003,501,0004,021,0001,111,0002,515,0002,616,0002,989,0001,066,0002,840,0002,584,0003,039,0001,262,0002,975,0003,183,0002,895,0001,358,0002,547,0002,662,000000000000000000000000000000000000
       Accounts payable 
0
0
0
428,000
366,000
344,000
414,000
455,000
1,378,000
428,000
368,000
420,000
399,000
379,000
368,000
478,000
352,000
419,000
433,000
418,000
367,000
430,000
454,000
566,000
396,000
503,000
448,000
591,000
441,000
441,000
525,000
697,000
512,000
566,000
527,000
675,000
550,000
615,000
659,000
751,000
636,000
664,000
673,000
859,000
679,000
664,000
623,000
814,000
563,000
572,000
531,000
1,036,000
597,000
755,000
826,000
1,242,000
1,242,000826,000755,000597,0001,036,000531,000572,000563,000814,000623,000664,000679,000859,000673,000664,000636,000751,000659,000615,000550,000675,000527,000566,000512,000697,000525,000441,000441,000591,000448,000503,000396,000566,000454,000430,000367,000418,000433,000419,000352,000478,000368,000379,000399,000420,000368,000428,0001,378,000455,000414,000344,000366,000428,000000
       Other Current Liabilities 
0
0
0
1,326,000
1,174,000
1,219,000
1,480,000
1,431,000
216,000
1,068,000
1,233,000
1,569,000
1,349,000
1,372,000
1,704,000
1,934,000
1,719,000
1,533,000
1,482,000
1,737,000
1,484,000
1,481,000
2,327,000
2,871,000
3,052,000
2,844,000
2,618,000
3,887,000
4,714,000
4,315,000
4,869,000
4,390,000
4,828,000
3,754,000
3,762,000
3,392,000
3,381,000
2,903,000
3,166,000
2,687,000
2,600,000
2,197,000
2,434,000
3,009,000
2,813,000
2,463,000
2,629,000
2,848,000
3,025,000
2,580,000
2,737,000
2,941,000
3,274,000
3,455,000
4,085,000
4,235,000
4,235,0004,085,0003,455,0003,274,0002,941,0002,737,0002,580,0003,025,0002,848,0002,629,0002,463,0002,813,0003,009,0002,434,0002,197,0002,600,0002,687,0003,166,0002,903,0003,381,0003,392,0003,762,0003,754,0004,828,0004,390,0004,869,0004,315,0004,714,0003,887,0002,618,0002,844,0003,052,0002,871,0002,327,0001,481,0001,484,0001,737,0001,482,0001,533,0001,719,0001,934,0001,704,0001,372,0001,349,0001,569,0001,233,0001,068,000216,0001,431,0001,480,0001,219,0001,174,0001,326,000000
   > Long-term Liabilities 
0
0
0
3,126,000
2,862,000
2,642,000
2,551,000
2,261,000
2,793,000
2,784,000
2,792,000
2,653,000
2,572,000
2,581,000
1,167,000
426,000
446,000
453,000
421,000
329,000
333,000
1,390,000
763,000
567,000
453,000
333,000
307,000
1,533,000
1,238,000
898,000
464,000
630,000
449,000
465,000
453,000
673,000
656,000
674,000
665,000
643,000
640,000
666,000
657,000
877,000
1,124,000
1,048,000
1,030,000
1,114,000
1,374,000
1,491,000
1,415,000
1,359,000
1,292,000
3,086,000
19,275,000
19,328,000
19,328,00019,275,0003,086,0001,292,0001,359,0001,415,0001,491,0001,374,0001,114,0001,030,0001,048,0001,124,000877,000657,000666,000640,000643,000665,000674,000656,000673,000453,000465,000449,000630,000464,000898,0001,238,0001,533,000307,000333,000453,000567,000763,0001,390,000333,000329,000421,000453,000446,000426,0001,167,0002,581,0002,572,0002,653,0002,792,0002,784,0002,793,0002,261,0002,551,0002,642,0002,862,0003,126,000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
465,000
453,000
575,000
656,000
573,000
568,000
552,000
548,000
578,000
573,000
743,000
706,000
646,000
650,000
684,000
903,000
1,036,000
982,000
910,000
862,000
2,603,000
2,399,000
2,473,000
2,473,0002,399,0002,603,000862,000910,000982,0001,036,000903,000684,000650,000646,000706,000743,000573,000578,000548,000552,000568,000573,000656,000575,000453,000465,000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
2,850,000
2,879,000
3,080,000
3,122,000
3,452,000
3,522,000
3,774,000
3,987,000
4,478,000
4,440,000
4,968,000
5,398,000
6,042,000
5,921,000
6,350,000
6,155,000
6,769,000
6,090,000
5,847,000
5,423,000
6,283,000
5,395,000
6,473,000
5,793,000
4,706,000
4,026,000
4,923,000
4,499,000
5,068,000
4,214,000
5,064,000
4,958,000
5,952,000
4,711,000
5,376,000
5,202,000
6,418,000
5,192,000
6,173,000
5,939,000
6,913,000
5,451,000
6,586,000
6,362,000
7,406,000
5,770,000
6,936,000
6,927,000
8,168,000
6,419,000
7,273,000
7,275,000
8,292,000
8,292,0007,275,0007,273,0006,419,0008,168,0006,927,0006,936,0005,770,0007,406,0006,362,0006,586,0005,451,0006,913,0005,939,0006,173,0005,192,0006,418,0005,202,0005,376,0004,711,0005,952,0004,958,0005,064,0004,214,0005,068,0004,499,0004,923,0004,026,0004,706,0005,793,0006,473,0005,395,0006,283,0005,423,0005,847,0006,090,0006,769,0006,155,0006,350,0005,921,0006,042,0005,398,0004,968,0004,440,0004,478,0003,987,0003,774,0003,522,0003,452,0003,122,0003,080,0002,879,0002,850,000000
   Common Stock
0
0
0
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
225,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
220,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000
216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000216,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000220,000225,000225,000225,000225,000225,000225,000225,000225,000225,000225,000225,000225,000225,000225,000000
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000000000000000000000000000
   Capital Surplus 00000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
251,000
-44,000
-60,000
-128,000
-21,000
-44,000
34,000
40,000
-32,000
-99,000
-63,000
-72,000
-40,000
34,000
660,000
77,000
1,419,000
-43,000
705,000
-183,000
1,358,000
-205,000
815,000
-200,000
1,630,000
-5,000
959,000
-78,000
1,868,000
-84,000
886,000
-7,000
2,197,000
-45,000
950,000
-167,000
2,139,000
-135,000
897,000
-134,000
2,321,000
-246,000
771,000
-278,000
2,450,000
-322,000
640,000
-400,000
2,546,000
-465,000
875,000
-370,000
-495,000
-495,000-370,000875,000-465,0002,546,000-400,000640,000-322,0002,450,000-278,000771,000-246,0002,321,000-134,000897,000-135,0002,139,000-167,000950,000-45,0002,197,000-7,000886,000-84,0001,868,000-78,000959,000-5,0001,630,000-200,000815,000-205,0001,358,000-183,000705,000-43,0001,419,00077,000660,00034,000-40,000-72,000-63,000-99,000-32,00040,00034,000-44,000-21,000-128,000-60,000-44,000251,000000



Balance Sheet

Currency in DKK. All numbers in thousands.




Cash Flow

Currency in DKK. All numbers in thousands.




Income Statement

Currency in DKK. All numbers in thousands.